These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12868334)

  • 1. Weighted DPOAE input/output-functions: a tool for automatic assessment of hearing loss in clinical application.
    Oswald JA; Janssen T
    Z Med Phys; 2003; 13(2):93-8. PubMed ID: 12868334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical test performance of distortion-product otoacoustic emissions using new stimulus conditions.
    Johnson TA; Neely ST; Kopun JG; Dierking DM; Tan H; Gorga MP
    Ear Hear; 2010 Feb; 31(1):74-83. PubMed ID: 19701088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cochlear compression estimates from measurements of distortion-product otoacoustic emissions.
    Neely ST; Gorga MP; Dorn PA
    J Acoust Soc Am; 2003 Sep; 114(3):1499-507. PubMed ID: 14514203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
    Janssen T; Niedermeyer HP; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-retest reliability of distortion-product thresholds compared to behavioral auditory thresholds.
    Bader K; Dierkes L; Braun LH; Gummer AW; Dalhoff E; Zelle D
    Hear Res; 2021 Jul; 406():108232. PubMed ID: 33984603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-source interference as the major reason for auditory-threshold estimation error based on DPOAE input-output functions in normal-hearing subjects.
    Dalhoff E; Turcanu D; Vetešník A; Gummer AW
    Hear Res; 2013 Feb; 296():67-82. PubMed ID: 23268357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of TEOAE and DPOAE measurements for the assessment of auditory thresholds in sensorineural hearing loss.
    Suckfüll M; Schneeweiss S; Dreher A; Schorn K
    Acta Otolaryngol; 1996 Jul; 116(4):528-33. PubMed ID: 8831837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle ear and cochlear disorders result in different DPOAE growth behaviour: implications for the differentiation of sound conductive and cochlear hearing loss.
    Gehr DD; Janssen T; Michaelis CE; Deingruber K; Lamm K
    Hear Res; 2004 Jul; 193(1-2):9-19. PubMed ID: 15219315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M; Hustert B; Stoll W
    Audiology; 1998; 37(2):83-99. PubMed ID: 9547922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test-retest repeatability of distortion product otoacoustic emissions.
    Wagner W; Heppelmann G; Vonthein R; Zenner HP
    Ear Hear; 2008 Jun; 29(3):378-91. PubMed ID: 18382378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DPOAE in tinnitus patients with cochlear hearing loss considering hyperacusis and misophonia].
    Sztuka A; Pośpiech L; Gawron W; Dudek K
    Otolaryngol Pol; 2006; 60(5):765-72. PubMed ID: 17263252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion product otoacoustic emissions and sensorineural hearing loss.
    Moulin A; Bera JC; Collet L
    Audiology; 1994; 33(6):305-26. PubMed ID: 7741665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.